Platelet kinetic studies in patients with idiopathic thrombocytopenic purpura

American Journal of Medicine

Volumn 106, Issue 4, 1999, Pages 430-434

  Louwes, Henk ^a   Lathori, Oscar A Zeinali ^b   Vellenga, Edo ^b   De Wolf, Joost Th M ^b  

^a MARTINI HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW BIOPSY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REMISSION; SPLENECTOMY; THROMBOCYTE; THROMBOCYTE FUNCTION; THROMBOCYTE LIFESPAN;

ADULT; AGED; BLOOD PLATELETS; CELL SURVIVAL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; KINETICS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

EID: 0033119756     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00054-6     Document Type: Article

References (21)

1. George J.N., El-Harake M.A., Aster R.H. Thrombocytopenia due to enhanced platelet destruction by immunologic mechanisms. Beutler E., Lichtman M.A., Coller B.S., Kipps T.J., Williams Hematology. 1995;1315-1355 McGraw-Hill, New York.
2. Shulman N.R., Marder V.J., Weinrach R.S. Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic purpura. Physiologic, serologic and isotopic studies. Ann N Y Acad Sci. 124:1965;499-542.
3. von dem Borne A.E.G.Kr., Vos J.J.E., van der Lelie J., Bossers B., van Dalen C.M. Clinical significance of positive platelet immunofluorescence test in thrombocytopenia. Br J Haematol. 64:1986;767-776.
4. Reisner E.H., Keating R.P., Friesen C., Loeffler E. Survival of sodium chromate-51 labelled platelets in animals and man. Proceedings of the 6th Congress of the International Society of Hematology. 1956;292-296 Grune & Stratton, New York.
5. Cohen P., Gardner F.H., Barnett G.O. Reclassification of the thrombocytopenias by the Cr51-labelling method for measuring platelet life span. NEJM. 264:1961;1294-1299.
6. Thakur M.L., Welch M.J., Malech H.L. Indium-111 labeled human platelets studies on preparation and evaluation in vitro and in vivo functions. Thromb Res. 9:1976;345-357.
7. Rodrigues M., Sinzinger H. Platelet labelling methodology and clinical applications. Thromb Res. 76:1994;399-432.
8. ICSH panel on diagnostic application of radioisotopes in haematology. Recommended method for Indium-111 platelet survival studies. J Nucl Med. 1988;29:564-566.
9. Nadler S.B., Hidalgo J.V., Bloch T. Prediction of blood volume in normal human adults. Surgery. 51:1962;224-232.
10. Harker L.A., Finch C.A. Thrombokinetics in man. J Clin Invest. 48:1969;963-974.
11. 111In-tropolonate. Kessler C.H., Hardeman M.R., Henningsen H., Petrovici J.N., Clinical Application of Radiolabelled Platelets. 1990;45-60 Kluwer Academic, Dordrecht, The Netherlands.
12. Fleming J.S. A technique for the measurement of activity using a gamma camera and computer. Phys Med Biol. 24:1979;176-180.
13. Hou M., Andersson P.O., Stockelberg D., Mellqvist U.V., Ridell B., Wadenvik H. Plasma thrombopoietin levels in thrombocytopenic states implication for a regulatory role of bone marrow megakaryocytes. Br J Haematol. 101:1998;420-424.
14. Emmons R.V.B., Reid D.M., Cohen R.L., Meng G., Young N.S., Dunbar C.E., Shulman N.R. Human thrombopoietin (TPO) levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood. 87:1996;4068-4071.
15. Schrezenmeier H., Griesshammer M., Hornkohl A., Nichol J.L., Hecht T., Heimpel H., Kubanek B., Raghavachar A. Thrombopoietin serum levels in patients with aplastic anaemia correlation with platelet count and persistent elevation in remission. Br J Haematol. 100:1998;571-576.
16. Cole J.L., Marzec U.M., Gunthel C.J., Karpatkin S., Worford L., Sundell B., Lennox J.L., Nichol J.L., Harker L.A. Ineffective platelet production in thrombocytopenic human immunodeficiency virus-infected patients. Blood. 91:1998;239-246.
17. Gernsheimer T., Stratton J., Ballem P.J., Slichter S.J. Mechanism of response to treatment in autoimmune thrombocytopenic purpura. NEJM. 320:1989;974-980.
18. 51Cr-labeled platelets differ. Blood. 67:1986;86-92.
19. Kernoff L.M., Blake K.C.H., Shackleton D. Influence of the amount of platelet-bound IgG on platelet survival and site of sequestration in autoimmune thrombocytopenia. Blood. 55:1980;730-733.
20. McMillan R., Luiken C.G.A., Levy R., Yelenosky R., Longmire R.L. Antibody against megakaryocytes in idiopathic thrombocytopenic purpura. JAMA. 239:1978;2460-2462.
21. Menke D.M., Colon-Otero G., Cockerill K.J., Jenkins R.B., Noel P., Pierre R.V. Refractory thrombocytopenia. A myelodysplastic syndrome that may mimic immune thrombocytopenic purpura. Am J Clin Pathol. 98:1992;502-510.